Get startedLog in
    Picture of Panacea Biotec logo

    PANACEABIO — Panacea Biotec News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Panacea Biotec, Apotex Enters Into Settlement Agreement With Celgene Corp

    Picture of Panacea Biotec logoPanacea Biotec
    15/06/2018 12:58
    June 15 (Reuters) - Panacea Biotec Ltd:
    * CO WITH PARTNER APOTEX ENTERED SETTLEMENT AGREEMENT WITH
CELGENE
CORPORATION
    * SETTLEMENT FOR DISPUTES ON PATENTS COVERING ABRAXANE DRUG
, CO'S
ANDA FOR PACLITAXEL PROTEIN BOUND PARTICLES FOR INJECTABLE
SUSPENSION
    * AS PART OF SETTLEMENT, CO, APOTEX WILL GET NONEXCLUSIVE
LICENSE;
MAY BEGIN SELLING CO'S GENERIC VERSION OF ABRAXANE IN U.S.,
TERRITORIES
    * OTHER TERMS OF AGREEMENT ARE CONFIDENTIAL

Source text: http://bit.ly/2sXKZEc
Further company coverage:  CELG.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Panacea Biotec

    See all news